Zobrazeno 1 - 10
of 35
pro vyhledávání: '"STOREY, DAVID E."'
Autor:
Storey, David E., Christman, Phil
Publikováno v:
The New Atlantis, 2021 Oct 01(66), 131-136.
Externí odkaz:
https://www.jstor.org/stable/27115513
Autor:
Mason, Laura Michelle, Campiñez, María Dolores, Pygall, Samuel R., Burley, Jonathan C., Gupta, Pranav, Storey, David E., Caraballo, Isidoro, Melia, Colin D.
Publikováno v:
In European Journal of Pharmaceutics and Biopharmaceutics August 2015 94:485-492
Autor:
STOREY, DAVID E.1, CHRISTMAN, PHIL
Publikováno v:
New Atlantis: A Journal of Technology & Society. Fall2021, Issue 66, p131-136. 6p.
Autor:
Storey, David E., 1982
In Naturalizing Heidegger, David E. Storey proposes a new interpretation of Heidegger's importance for environmental philosophy, finding in the development of his thought from the early 1920s to his later work in the 1940s the groundwork for a natura
Autor:
Hannah Batchelor, Storey David E, Tycho Heimbach, Ann Marie Kaukonen, Rob Ju, Sandra Klein, Jian Wang, Wen Lin, Barbara M. Davit, Robert Louis Ternik
Publikováno v:
International Journal of Pharmaceutics. 536:530-535
A small amount of food is commonly used to aid administration of medicines to children to improve palatability and/or swallowability. However the impact of this co-administered food on the absorption and subsequent pharmacokinetic profile of the drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6cb4191f0ca575c452dc248b342d856
https://doi.org/10.1016/j.ijpharm.2017.05.011
https://doi.org/10.1016/j.ijpharm.2017.05.011
Autor:
Storey David E, Simona Chessa, Pranav Gupta, Hiep Huatan, Jonathan C. Burley, Laura M. Mason, Colin D. Melia
Publikováno v:
International Journal of Pharmaceutics. 510:210-220
The Dynamic Gastric Model (DGM) is an in-vitro system which aims to closely replicate the complex mixing, dynamic biochemical release and emptying patterns of the human stomach. In this study, the DGM was used to understand how the polymer content of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f4f2f904863b9909f215b7dbc16efb
https://doi.org/10.1016/j.ijpharm.2016.06.034
https://doi.org/10.1016/j.ijpharm.2016.06.034
Autor:
Terry B. Ernest, Talia Flanagan, Storey David E, Nikoletta Fotaki, Sandra Klein, Hannah Batchelor, Roy Turner
Publikováno v:
Batchelor, H, Ernest, T, Flanagan, T, Klein, S, Turner, R, Fotaki, N & Storey, D 2016, ' Towards the development of a paediatric biopharmaceutics classification system : results of a survey of experts ', International Journal of Pharmaceutics, vol. 511, no. 2, pp. 1151-1157 . https://doi.org/10.1016/j.ijpharm.2016.06.115
The aim of this research survey was to understand current global thinking around the need for and development of a paediatric biopharmaceutics classification system (pBCS) to be used for the development of paediatric medicines and regulatory purposes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b00ab4d34b4f25bfd5cfcbb49dd1aa
https://strathprints.strath.ac.uk/73396/1/Batchelor_etal_IJP_2016_Towards_the_development_of_a_paediatric_biopharmaceutics_classification_system.pdf
https://strathprints.strath.ac.uk/73396/1/Batchelor_etal_IJP_2016_Towards_the_development_of_a_paediatric_biopharmaceutics_classification_system.pdf
Results of an industry survey to understand current practice in bridging for paediatric formulations
Autor:
Talia Flanagan, Hannah Batchelor, Storey David E, Nikoletta Fotaki, Roy Turner, Sandra Klein, Terry B. Ernest
Publikováno v:
International Journal of Pharmaceutics. 536:521
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::863e84a16e51d8db60dd91e6959e4006
https://doi.org/10.1016/j.ijpharm.2017.08.055
https://doi.org/10.1016/j.ijpharm.2017.08.055
Autor:
Karen C. Thompson, Alice E Loper, Linda Novak, Yunhui Wu, Cindy Chen, Gloria Y. Kwei, Lisa Hettrick, Kari Lynn, Storey David E, Udit Batra, Ray Higgins, Elizabeth Landis, Suhas D. Shelukar
Publikováno v:
International Journal of Pharmaceutics. 285:135-146
MK-0869 (aprepitant), a potent substance P antagonist, is the active ingredient of EMEND which has recently been approved by the FDA for the prevention of chemotherapy-induced nausea and vomiting. Early clinical tablet formulations of MK-0869 showed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d6d7c2875f237cd47c3626cea9cab0
https://doi.org/10.1016/j.ijpharm.2004.08.001
https://doi.org/10.1016/j.ijpharm.2004.08.001
Publikováno v:
International Journal of Pharmaceutics. 511:1129-1130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::366b5f59d820f7f71dcef75eb154ecdd
https://doi.org/10.1016/j.ijpharm.2016.06.067
https://doi.org/10.1016/j.ijpharm.2016.06.067